OTC Markets OTCPK - Delayed Quote USD
Guardion Health Sciences, Inc. (GHSI)
At close: November 21 at 3:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
12,228.7130
12,248.5500
11,049.7720
7,233.1170
1,889.8440
Cost of Revenue
6,779.6370
6,854.0330
6,529.3850
4,122.6840
1,946.6350
Gross Profit
5,449.0760
5,394.5170
4,520.3870
3,110.4340
-56.7910
Operating Expense
9,024.6890
9,336.2890
11,841.4470
13,593.8120
8,445.4920
Operating Income
-3,575.6130
-3,941.7720
-7,321.0600
-10,483.3780
-8,502.2830
Net Non Operating Interest Income Expense
377.8770
379.5200
152.5700
1.7970
-7.2710
Other Income Expense
-2,077.2780
3,720.2840
-7,753.7380
-14,263.4280
-62.1030
Pretax Income
-5,275.0140
158.0320
-14,922.2280
-24,745.0090
-8,571.6570
Net Income Common Stockholders
6,374.9400
158.0330
-15,863.8130
-24,745.0090
-8,571.6570
Diluted NI Available to Com Stockholders
6,374.9400
158.0330
-15,863.8130
-24,745.0090
-8,571.6570
Basic EPS
4.97
0.12
-14.15
-52.23
-30.00
Diluted EPS
4.97
0.12
-14.15
-52.23
-30.00
Basic Average Shares
1,278.2960
1,270.8460
1,121.0000
473.7720
285.1370
Diluted Average Shares
1,278.2960
1,270.8460
1,121.0000
473.7720
285.1370
Total Operating Income as Reported
-3,987.3870
-4,336.3170
-17,420.5980
-24,746.8060
-8,551.7310
Total Expenses
15,804.3260
16,190.3220
18,370.8320
17,716.4960
10,392.1270
Net Income from Continuing & Discontinued Operation
6,374.9400
158.0330
-14,922.2280
-24,745.0090
-8,571.6570
Normalized Income
-3,517.3600
-3,562.2510
-7,168.4900
-10,481.5810
-8,509.5540
Interest Income
377.8770
379.5200
152.5700
1.7970
--
Interest Expense
--
--
--
--
7.2710
Net Interest Income
377.8770
379.5200
152.5700
1.7970
-7.2710
EBIT
-3,575.6130
-3,941.7720
-7,321.0600
-10,483.3780
-8,564.3860
EBITDA
-3,556.4540
-3,922.3540
-6,072.2710
-9,700.4580
-8,344.7860
Reconciled Cost of Revenue
6,779.6370
6,854.0330
6,529.3850
4,122.6840
1,946.6350
Reconciled Depreciation
19.1590
19.4180
1,248.7890
782.9200
219.6000
Net Income from Continuing Operation Net Minority Interest
-5,275.0130
158.0330
-14,922.2280
-24,745.0090
-8,571.6570
Total Unusual Items Excluding Goodwill
-1,757.6530
3,720.2840
-7,753.7380
-14,263.4280
-62.1030
Total Unusual Items
-1,757.6530
3,720.2840
-7,753.7380
-14,263.4280
-62.1030
Normalized EBITDA
-1,798.8010
-7,642.6380
1,681.4670
4,562.9700
-8,282.6830
12/31/2020 - 4/5/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SXTC China SXT Pharmaceuticals, Inc.
0.3829
-1.57%
PTPI Petros Pharmaceuticals, Inc.
0.2699
+5.02%
BVF.F Bausch Health Companies Inc.
7.74
+0.40%
VYYRF Voyageur Pharmaceuticals Ltd.
0.0500
0.00%
DHBUF Delivra Health Brands Inc.
0.0140
0.00%
NTRR Neutra Corp.
0.0001
0.00%
AYURF Ayurcann Holdings Corp.
0.0220
0.00%
ATTBF Abattis Bioceuticals Corp.
0.0001
0.00%
CPHI China Pharma Holdings, Inc.
0.1925
-3.27%
ROMJF Rubicon Organics Inc.
0.2150
-0.05%